Alliancebernstein L.P. decreased its stake in shares of Accuray Incorporated (NASDAQ:ARAY) by 8.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 85,491 shares of the medical equipment provider’s stock after selling 7,500 shares during the period. Alliancebernstein L.P.’s holdings in Accuray were worth $406,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of ARAY. RNC Capital Management LLC increased its stake in shares of Accuray by 5.0% in the first quarter. RNC Capital Management LLC now owns 27,500 shares of the medical equipment provider’s stock valued at $131,000 after buying an additional 1,300 shares in the last quarter. Fox Run Management L.L.C. acquired a new stake in shares of Accuray during the first quarter valued at approximately $141,000. Advisory Services Network LLC acquired a new stake in shares of Accuray during the first quarter valued at approximately $154,000. Acadian Asset Management LLC increased its stake in shares of Accuray by 14.2% in the first quarter. Acadian Asset Management LLC now owns 47,765 shares of the medical equipment provider’s stock valued at $227,000 after buying an additional 5,926 shares in the last quarter. Finally, Engineers Gate Manager LP increased its stake in shares of Accuray by 196.9% in the first quarter. Engineers Gate Manager LP now owns 48,054 shares of the medical equipment provider’s stock valued at $228,000 after buying an additional 31,871 shares in the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

Accuray Incorporated (NASDAQ ARAY) traded down 1.22% during trading on Friday, hitting $4.05. The stock had a trading volume of 15,407 shares. The company’s 50 day moving average is $4.48 and its 200 day moving average is $4.70. The firm’s market cap is $336.15 million. Accuray Incorporated has a 52-week low of $3.85 and a 52-week high of $6.39.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.watchlistnews.com/accuray-incorporated-nasdaqaray-position-reduced-by-alliancebernstein-l-p/1475029.html.

A number of equities analysts have recently issued reports on the company. Zacks Investment Research downgraded Accuray from a “buy” rating to a “hold” rating in a research note on Tuesday, May 2nd. Jefferies Group LLC restated a “buy” rating and issued a $7.00 price target on shares of Accuray in a research note on Wednesday. BTIG Research restated a “hold” rating on shares of Accuray in a research note on Sunday, April 30th. Finally, BidaskClub downgraded Accuray from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $7.04.

Accuray Company Profile

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy.

Want to see what other hedge funds are holding ARAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accuray Incorporated (NASDAQ:ARAY).

Institutional Ownership by Quarter for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.